BOLT vs CDW · rev $7.7M vs P/E 22, rev $21.00B
Bolt Biotherapeutics (BOLT) versus CDW Corp (CDW) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
CDW Corp (CDW) is a information technology services company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
BOLT currently screens at market cap $11.3M. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Not investment advice. Open the BOLT and CDW stock pages for the full models.
Not investment advice.